In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae

Journal of Chemotherapy

Volumn 12, Issue 1, 2000, Pages 17-21

  Gomez Lus, R ^a   Navarro, C ^b   Egido, P ^b   Aspiroz, C ^b   Goni P ^a   Vergara, Y ^a   Garcia, C ^a   Duran, E ^a   Castillo, J ^a   Rubio, M C ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b Hospital Comarcal   (Spain)

Author keywords

Cefepime; Cefotaxime; Fourth generation cephaloporins; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; IMIPENEM; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEPHALOSPORINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034057102     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Klugman K, Goldstein F, Kohno S, Baquero F. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997; (Supp. 1) 3: S4860.
2. Marton A. Pneumococcal antibiotic resistance: the problem in Hungary. Clin Infect Dis 1992; 15: 106-111.
3. Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis 1994; Suppl. 93: 55-62.
4. Goldstein FW, Acar JF and the Alexander Project Collaborative Group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-1993 Western Europe and USA collaborative surveillance study. Antimicrob Chemother 1996; 38 (Suppl. A): 71-84.
5. Baquero F, Martínez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 (Suppl.C): 31-38.
6. Fenoll A, Martín-Bourgon C, Muñoz R, Vicioso S, Casal J. Serotype, distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain. Rev Infect Dis 1991; 13: 56-60.
7. Liñares J, Garau J, Domínguez C, Pérez J L. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community acquired pneumococcal disease. Antimicrob Agents Chemother 1983; 23: 545-547.
8. Liñares J, Alonso T, Pérez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-288.
9. Klugman K. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
10. Gómez-Lus R, Adrián F, Gömez-Lus S, Rubio MC. Presión selectiva antibiótica y resistencia en infecciones por Streptococcus pneumoniae. M Clin (Barc) 1998; 110 (Supl.1): 3-7.
11. Lee HJ, Park JY, Jang SH, Kim JH. High incidence of resistance to multiple antimicrobials in clinical isolates of S. pneumoniae from a University Hospital in Korea. Clin Infect Dis 1995, 20: 826-835.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard M7-A4. NCCLS, Wayne, Pa. 1997.
13. Martínez-Beltrán J, Cantón R, Liñares J. Multicenter comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin. Eur J Clin Microbiol Infect Dis 1995; 14: 244-252.
14. Goldstein F, Briskier A, Appelbaum PC, et al. The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other antimicrobial agents against respiratory pathogens. Clin Microbiol Infect 1998; 4 (Suppl 2): 2S8-2S18.
15. Baquero F, García-Rodríguez JA, García de Lomas J, Aguilar L, and the Spanish Surveillance Group for respiratory pathogens. Antimicrob Agents Chemother 1999; 43: 357-359.